{"id":"W2061718990","doi":"10.1182/blood-2008-08-175323","title":"Adverse events among 2408 unrelated donors of peripheral blood stem cells: results of a prospective trial from the National Marrow Donor Program","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":269,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"National Institute of Allergy and Infectious Diseases; National Cancer Institute; Office of Naval Research; Takeda Oncology; National Institutes of Health; Otsuka Pharmaceutical; Astellas Pharma; Therakos; Kiadis Pharma; Association of Medical Microbiology and Infectious Disease Canada; American Society for Blood and Marrow Transplantation; Teva Pharmaceutical Industries; WellPoint; HistoGenetics; CellGenix; Medical College of Wisconsin; Enzon Pharmaceuticals; U.S. Navy; Centers for Disease Control and Prevention; Celgene; Osiris Therapeutics; Pfizer; Baxter International; Health Resources and Services Administration; Viropharma; Amgen; Blue Cross and Blue Shield Association; U.S. Department of Health and Human Services; Astellas Pharma US; Bayer HealthCare; U.S. Department of Defense","keywords":"Medicine; Filgrastim; Adverse effect; Nausea; Internal medicine; Surgery; Apheresis; Granulocyte colony-stimulating factor; Bone marrow; Odds ratio; Donation; Chemotherapy; Platelet","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003911123,0.000193135,0.0004051303,0.0000684882,0.00004915052,0.000005122135,0.0001374426,0.0001681687,0.00004190866],"category_scores_gemma":[0.00007067064,0.0001404596,0.0001899113,0.0003148092,0.00009963032,0.00008050205,0.00001177502,0.0002090613,0.000005234578],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00003714646,"about_ca_system_score_gemma":0.0001858066,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001764428,"about_ca_topic_score_gemma":0.00003756136,"domain_scores_codex":[0.9978925,0.0001316413,0.0007527717,0.0003296153,0.0006845933,0.0002088649],"domain_scores_gemma":[0.9987715,0.0002160042,0.0003872715,0.0002481344,0.0002891648,0.0000879604],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.183428,0.05053564,0.4957985,0.0009190232,0.007159649,0.0002793627,0.04173179,0.0003421548,0.2135567,0.0007096517,0.000808709,0.004730765],"study_design_scores_gemma":[0.290891,0.005264473,0.3634258,0.00120345,0.002541086,0.00004048793,0.000958675,0.0002401984,0.3346814,0.0003773576,0.00005206584,0.0003239837],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9944645,0.00007282665,0.00001239412,0.0001502584,0.0001316534,0.00268983,0.0002103557,0.00006649213,0.002201689],"genre_scores_gemma":[0.9979951,0.00003095711,0.00132937,0.00003292958,0.0001525358,0.00007816964,0.0001047013,0.00001837088,0.0002577983],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1323727,"threshold_uncertainty_score":0.5727776,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0164950481682837,"score_gpt":0.2625234781842674,"score_spread":0.2460284300159837,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}